Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017

Rachele Ciccocioppo, Claudia C. Dos Santos, Daniel C. Baumgart, Giuseppina C. Cangemi, Vincenzo Cardinale, Carolina Ciacci, Paolo De Coppi, Debashis Haldar, Catherine Klersy, M. Cristina Nostro, Michael Ott, Lorenzo Piemonti, Alice Tomei, Basak Uygun, Stefania Vetrano, Giuseppe Orlando

Research output: Contribution to journalArticle

Abstract

A summary of the First Signature Series Event, "Advancements in Cellular Therapies and Regenerative Medicine for Digestive Diseases," held on May 3, 2017, in London, United Kingdom, is presented. Twelve speakers from three continents covered major topics in the areas of cellular therapy and regenerative medicine applied to liver and gastrointestinal medicine as well as to diabetes mellitus. Highlights from their presentations, together with an overview of the global impact of digestive diseases and a proposal for a shared online collection and data-monitoring platform tool, are included in this proceedings. Although growing evidence demonstrate the feasibility and safety of exploiting cell-based technologies for the treatment of digestive diseases, regulatory and methodological obstacles will need to be overcome before the successful implementation in the clinic of these novel attractive therapeutic strategies.

Original languageEnglish (US)
JournalCytotherapy
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Regenerative Medicine
Diabetes Mellitus
Therapeutics
Medicine
Technology
Safety
Liver
United Kingdom

Keywords

  • Digestive diseases
  • Immune tolerance
  • Mesenchymal stromal cells
  • Tissue regeneration

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology
  • Genetics(clinical)
  • Cell Biology
  • Transplantation
  • Cancer Research

Cite this

Proceedings of the signature series event of the international society for cellular therapy : "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017. / Ciccocioppo, Rachele; Dos Santos, Claudia C.; Baumgart, Daniel C.; Cangemi, Giuseppina C.; Cardinale, Vincenzo; Ciacci, Carolina; De Coppi, Paolo; Haldar, Debashis; Klersy, Catherine; Nostro, M. Cristina; Ott, Michael; Piemonti, Lorenzo; Tomei, Alice; Uygun, Basak; Vetrano, Stefania; Orlando, Giuseppe.

In: Cytotherapy, 01.01.2018.

Research output: Contribution to journalArticle

Ciccocioppo, R, Dos Santos, CC, Baumgart, DC, Cangemi, GC, Cardinale, V, Ciacci, C, De Coppi, P, Haldar, D, Klersy, C, Nostro, MC, Ott, M, Piemonti, L, Tomei, A, Uygun, B, Vetrano, S & Orlando, G 2018, 'Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017', Cytotherapy. https://doi.org/10.1016/j.jcyt.2017.12.004
Ciccocioppo, Rachele ; Dos Santos, Claudia C. ; Baumgart, Daniel C. ; Cangemi, Giuseppina C. ; Cardinale, Vincenzo ; Ciacci, Carolina ; De Coppi, Paolo ; Haldar, Debashis ; Klersy, Catherine ; Nostro, M. Cristina ; Ott, Michael ; Piemonti, Lorenzo ; Tomei, Alice ; Uygun, Basak ; Vetrano, Stefania ; Orlando, Giuseppe. / Proceedings of the signature series event of the international society for cellular therapy : "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017. In: Cytotherapy. 2018.
@article{cf9971e6f89b456284e9609cc0942c80,
title = "Proceedings of the signature series event of the international society for cellular therapy: {"}Advancements in cellular therapies and regenerative medicine in digestive diseases,{"} London, United Kingdom, May 3, 2017",
abstract = "A summary of the First Signature Series Event, {"}Advancements in Cellular Therapies and Regenerative Medicine for Digestive Diseases,{"} held on May 3, 2017, in London, United Kingdom, is presented. Twelve speakers from three continents covered major topics in the areas of cellular therapy and regenerative medicine applied to liver and gastrointestinal medicine as well as to diabetes mellitus. Highlights from their presentations, together with an overview of the global impact of digestive diseases and a proposal for a shared online collection and data-monitoring platform tool, are included in this proceedings. Although growing evidence demonstrate the feasibility and safety of exploiting cell-based technologies for the treatment of digestive diseases, regulatory and methodological obstacles will need to be overcome before the successful implementation in the clinic of these novel attractive therapeutic strategies.",
keywords = "Digestive diseases, Immune tolerance, Mesenchymal stromal cells, Tissue regeneration",
author = "Rachele Ciccocioppo and {Dos Santos}, {Claudia C.} and Baumgart, {Daniel C.} and Cangemi, {Giuseppina C.} and Vincenzo Cardinale and Carolina Ciacci and {De Coppi}, Paolo and Debashis Haldar and Catherine Klersy and Nostro, {M. Cristina} and Michael Ott and Lorenzo Piemonti and Alice Tomei and Basak Uygun and Stefania Vetrano and Giuseppe Orlando",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jcyt.2017.12.004",
language = "English (US)",
journal = "Cytotherapy",
issn = "1465-3249",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Proceedings of the signature series event of the international society for cellular therapy

T2 - "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017

AU - Ciccocioppo, Rachele

AU - Dos Santos, Claudia C.

AU - Baumgart, Daniel C.

AU - Cangemi, Giuseppina C.

AU - Cardinale, Vincenzo

AU - Ciacci, Carolina

AU - De Coppi, Paolo

AU - Haldar, Debashis

AU - Klersy, Catherine

AU - Nostro, M. Cristina

AU - Ott, Michael

AU - Piemonti, Lorenzo

AU - Tomei, Alice

AU - Uygun, Basak

AU - Vetrano, Stefania

AU - Orlando, Giuseppe

PY - 2018/1/1

Y1 - 2018/1/1

N2 - A summary of the First Signature Series Event, "Advancements in Cellular Therapies and Regenerative Medicine for Digestive Diseases," held on May 3, 2017, in London, United Kingdom, is presented. Twelve speakers from three continents covered major topics in the areas of cellular therapy and regenerative medicine applied to liver and gastrointestinal medicine as well as to diabetes mellitus. Highlights from their presentations, together with an overview of the global impact of digestive diseases and a proposal for a shared online collection and data-monitoring platform tool, are included in this proceedings. Although growing evidence demonstrate the feasibility and safety of exploiting cell-based technologies for the treatment of digestive diseases, regulatory and methodological obstacles will need to be overcome before the successful implementation in the clinic of these novel attractive therapeutic strategies.

AB - A summary of the First Signature Series Event, "Advancements in Cellular Therapies and Regenerative Medicine for Digestive Diseases," held on May 3, 2017, in London, United Kingdom, is presented. Twelve speakers from three continents covered major topics in the areas of cellular therapy and regenerative medicine applied to liver and gastrointestinal medicine as well as to diabetes mellitus. Highlights from their presentations, together with an overview of the global impact of digestive diseases and a proposal for a shared online collection and data-monitoring platform tool, are included in this proceedings. Although growing evidence demonstrate the feasibility and safety of exploiting cell-based technologies for the treatment of digestive diseases, regulatory and methodological obstacles will need to be overcome before the successful implementation in the clinic of these novel attractive therapeutic strategies.

KW - Digestive diseases

KW - Immune tolerance

KW - Mesenchymal stromal cells

KW - Tissue regeneration

UR - http://www.scopus.com/inward/record.url?scp=85041579855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041579855&partnerID=8YFLogxK

U2 - 10.1016/j.jcyt.2017.12.004

DO - 10.1016/j.jcyt.2017.12.004

M3 - Article

C2 - 29398624

AN - SCOPUS:85041579855

JO - Cytotherapy

JF - Cytotherapy

SN - 1465-3249

ER -